Abacus Life Announces Proposed Public Offering of Common Stock

Core Viewpoint - Abacus Life, Inc. has initiated an underwritten public offering of 10,000,000 shares of its common stock, with an option for underwriters to purchase an additional 1,500,000 shares [1][2] Group 1: Offering Details - The public offering is subject to general market conditions, and there are no assurances regarding its completion or terms [2] - A registration statement on Form S-1 has been filed with the SEC, but it has not yet become effective [3] Group 2: Use of Proceeds - Abacus plans to use the net proceeds from the offering for operations, including purchasing life settlement policies, supporting its business strategy, working capital, and potentially repaying or refinancing its debt [1] Group 3: Company Overview - Abacus is a leading alternative asset manager specializing in longevity and actuarial technology, with over $5 billion in face value of life insurance policies purchased since 2004 [5] - The company operates three channels: ABL Tech, ABL Wealth, and ABL Longevity Funds, and is the only public life settlement company listed on the Nasdaq Exchange under the ticker symbol ABL [5]